MX2017006712A - Inhibidor de produccion de metaloproteinasa de matriz. - Google Patents

Inhibidor de produccion de metaloproteinasa de matriz.

Info

Publication number
MX2017006712A
MX2017006712A MX2017006712A MX2017006712A MX2017006712A MX 2017006712 A MX2017006712 A MX 2017006712A MX 2017006712 A MX2017006712 A MX 2017006712A MX 2017006712 A MX2017006712 A MX 2017006712A MX 2017006712 A MX2017006712 A MX 2017006712A
Authority
MX
Mexico
Prior art keywords
matrix metalloproteinase
production inhibitor
metalloproteinase production
compound
inhibitor
Prior art date
Application number
MX2017006712A
Other languages
English (en)
Inventor
Misawa Eriko
Yao Ruiqing
SAITO Marie
Tanaka Miyuki
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of MX2017006712A publication Critical patent/MX2017006712A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona un inhibidor de producción de metaloproteinasa de matriz que se puede tomar diariamente de manera segura. En el inhibidor de producción de metaloproteinasa de matriz, un compuesto seleccionado del grupo que consiste de un compuesto de lofenol y un compuesto de ciclolanostano se utiliza como un ingrediente activo.
MX2017006712A 2014-11-28 2015-11-27 Inhibidor de produccion de metaloproteinasa de matriz. MX2017006712A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014241923 2014-11-28
PCT/JP2015/083476 WO2016084957A1 (ja) 2014-11-28 2015-11-27 マトリックスメタロプロテアーゼ産生阻害剤

Publications (1)

Publication Number Publication Date
MX2017006712A true MX2017006712A (es) 2017-09-01

Family

ID=56074502

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006712A MX2017006712A (es) 2014-11-28 2015-11-27 Inhibidor de produccion de metaloproteinasa de matriz.

Country Status (7)

Country Link
US (1) US20170319600A1 (es)
EP (1) EP3225242A4 (es)
JP (1) JP6285050B2 (es)
KR (1) KR20170088965A (es)
CN (1) CN106999504A (es)
MX (1) MX2017006712A (es)
WO (1) WO2016084957A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20161079A1 (sr) 2016-12-06 2017-10-31 Dejan Vukićević Mobilna skela sa platformom, male visine i prvenstveno oslonjena na tlo
JP6792715B2 (ja) * 2017-08-30 2020-11-25 森永乳業株式会社 深部体温上昇用組成物
EP3777865A4 (en) * 2018-03-29 2022-01-19 Morinaga Milk Industry Co., Ltd. COMPOSITION AGAINST AGING
WO2019188490A1 (ja) * 2018-03-29 2019-10-03 森永乳業株式会社 紫外線抵抗性向上用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615546B2 (en) * 2005-08-19 2009-11-10 Bioderm Research Topical delivery system for phytosterols
AU2006300629B2 (en) * 2005-09-22 2009-12-10 Morinaga Milk Industry Co., Ltd. Agent for inhibiting Visceral fat accumulation
WO2007043306A1 (ja) * 2005-09-30 2007-04-19 Morinaga Milk Industry Co., Ltd. インスリン抵抗性改善剤
JP4176140B2 (ja) * 2005-09-30 2008-11-05 森永乳業株式会社 インスリン抵抗性改善剤
CN103494998B (zh) * 2005-11-25 2015-08-12 森永乳业株式会社 翠叶芦荟提取物、制备翠叶芦荟提取物的方法和高血糖改善剂
US7959952B2 (en) * 2006-09-01 2011-06-14 Nuliv Holding Inc. Method for skin care
US8168596B2 (en) * 2008-10-17 2012-05-01 Nuliv Holding Inc. Use of cycloartane compounds for treating arthritis
US8470807B2 (en) * 2008-11-19 2013-06-25 Morinaga Milk Industry Co., Ltd. Antioxidant

Also Published As

Publication number Publication date
US20170319600A1 (en) 2017-11-09
WO2016084957A1 (ja) 2016-06-02
EP3225242A4 (en) 2018-08-15
EP3225242A1 (en) 2017-10-04
CN106999504A (zh) 2017-08-01
KR20170088965A (ko) 2017-08-02
JPWO2016084957A1 (ja) 2017-04-27
JP6285050B2 (ja) 2018-02-28

Similar Documents

Publication Publication Date Title
MX2021004479A (es) Agentes biologicos y su uso en plantas.
PH12017502298A1 (en) Antibacterial compounds
MX2017002670A (es) Inhibidores de glucosidasa.
MX2019012096A (es) Inhibidor de melanogenesis que comprende alcohol d-pantotenilico, y cosmetico de blanqueamiento de la piel que contiene el mismo inhibidor de melanogenesis.
MX2020003430A (es) Derivados de 1-bencil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de proteasa de virus de inmunodeficiencia humana.
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
AU2015299431B2 (en) Pyrrolidinone derivatives as metAP-2 inhibitors
MX2017008414A (es) Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas.
ZA201704116B (en) 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine compound inhibitors of beta-secretase
GB2548277A (en) Antibiofilm compositions
EP3142659A4 (en) Hiv-1 protease inhibitors and uses thereof
PH12016501865A1 (en) Pyridine-2-amides useful as cb2 agonists
MX2021007899A (es) Composiciones con inhibidor selectivo de la trans-se?alizacion de il-6.
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
MX2017006712A (es) Inhibidor de produccion de metaloproteinasa de matriz.
IN2014MU00916A (es)
PH12017501022A1 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
MX368268B (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
GEP20217236B (en) Composition comprising pentose and polyphenolic compound
EP3113780A4 (en) Hiv protease inhibitors
SG11201903231WA (en) Microbioreactor module
EP3337567A4 (en) INHIBITORS OF HIV-1 PROTEASE AND USES THEREOF
EP3240540A4 (en) Hdac1,2 inhibitors and methods of using the same
AU367429S (en) Carboy
MY182603A (en) An extract of baeckea frutescens and its use in the treatment of gout